{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:26:27Z","timestamp":1792704387281,"version":"4.5.0"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T00:00:00Z","timestamp":1284336000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0012699","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T19:56:36Z","timestamp":1284407796000},"page":"e12699","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":103,"title":["Vascular Cellular Adhesion Molecule-1 (VCAM-1) Expression in Mice Retinal Vessels Is Affected by Both Hyperglycemia and Hyperlipidemia"],"prefix":"10.1371","volume":"5","author":[{"given":"Carin","family":"Gustavsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl-David","family":"Agardh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna V.","family":"Zetterqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Agardh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria F.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,9,13]]},"reference":[{"key":"ref1","first-page":"95103","article-title":"Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy.","author":"TS Kern","year":"2007","journal-title":"Exp Diabetes Res 2007"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3132\/dvdr.2007.025","article-title":"The endothelium and vascular inflammation in diabetes.","volume":"4","author":"MM Hartge","year":"2007","journal-title":"Diab Vasc Dis Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2337\/db05-1635","article-title":"Diabetic Retinopathy: Seeing Beyond Glucose-Induced Microvascular Disease.","volume":"55","author":"DA Antonetti","year":"2006","journal-title":"Diabetes"},{"key":"ref4","first-page":"31867","article-title":"Cellular signaling and potential new treatment targets in diabetic retinopathy.","author":"ZA Khan","year":"2007","journal-title":"Exp Diabetes Res 2007"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10735-007-9159-5","article-title":"Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes.","author":"T Khalfaoui","year":"2008","journal-title":"J Mol Histol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1210\/jc.2008-2534","article-title":"Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications.","volume":"94","author":"RB Goldberg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1161\/ATVBAHA.107.145821","article-title":"Endothelial signaling by Ig-like cell adhesion molecules.","volume":"27","author":"JD van Buul","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jdiacomp.2007.03.001","article-title":"TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.","volume":"22","author":"C Gustavsson","year":"2008","journal-title":"J Diabetes Complications"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.2337\/dc09-0102","article-title":"Inflammatory, Hemostatic, and Other Novel Biomarkers for Diabetic Retinopathy: The Multi-Ethnic Study of Atherosclerosis.","volume":"32","author":"TT Nguyen","year":"2009","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/archophthalmol.2009.172","article-title":"The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy.","volume":"127","author":"BE Klein","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis.","volume":"420","author":"P Libby","year":"2002","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-3083.2008.02029.x","article-title":"Soluble ICAM-1 and VCAM-1 as markers of endothelial activation.","volume":"67","author":"V Videm","year":"2008","journal-title":"Scand J Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1464-5491.2007.02217.x","article-title":"Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes.","volume":"24","author":"AM Spijkerman","year":"2007","journal-title":"Diabet Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jdiacomp.2005.06.005","article-title":"Soluble vascular cell adhesion molecule-1 and soluble E-selectin are associated with micro- and macrovascular complications in Type 1 diabetic patients.","volume":"20","author":"SS Soedamah-Muthu","year":"2006","journal-title":"J Diabetes Complications"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1076\/ceyr.19.3.219.5314","article-title":"Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.","volume":"19","author":"GR Barile","year":"1999","journal-title":"Curr Eye Res"},{"key":"ref16","first-page":"2453","article-title":"Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy.","volume":"40","author":"GA Limb","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/mvre.1994.1027","article-title":"Neutrophils plug capillaries in acute experimental retinal ischemia.","volume":"47","author":"DL Hatchell","year":"1994","journal-title":"Microvasc Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00417-008-0868-6","article-title":"Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes--role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy.","volume":"246","author":"J Adamiec-Mroczek","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1046\/j.1464-5491.2002.00799.x","article-title":"Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy.","volume":"19","author":"K Matsumoto","year":"2002","journal-title":"Diabet Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10238-008-0173-z","article-title":"Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy.","volume":"8","author":"M Nowak","year":"2008","journal-title":"Clin Exp Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","article-title":"Immune and inflammatory mechanisms of atherosclerosis (*).","volume":"27","author":"E Galkina","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.diabres.2005.03.015","article-title":"The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering?","volume":"68","author":"LA Leiter","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2337\/diab.46.11.1829","article-title":"Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.","volume":"46","year":"1997","journal-title":"Diabetes"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1167\/iovs.02-0648","article-title":"Diabetic retinopathy and serum lipoprotein subclasses in the DCCT\/EDIC cohort.","volume":"45","author":"TJ Lyons","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/eye.2008.428","article-title":"Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality?","volume":"23","author":"PM Dodson","year":"2009","journal-title":"Eye"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(07)61607-9","article-title":"Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.","volume":"370","author":"AC Keech","year":"2007","journal-title":"Lancet"},{"key":"ref27","first-page":"NEJMoa1001288","article-title":"The ASGaAESG Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes.","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1172\/JCI112130","article-title":"Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system.","volume":"76","author":"JK Boyles","year":"1985","journal-title":"J Clin Invest"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00281-008-0111-x","article-title":"Immunological mechanisms in the pathogenesis of diabetic retinopathy.","volume":"30","author":"AP Adamis","year":"2008","journal-title":"Semin Immunopathol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.2741\/2881","article-title":"Tumor necrosis factor (TNF) biology and cell death.","volume":"13","author":"L Bertazza","year":"2008","journal-title":"Front Biosci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.tins.2008.07.005","article-title":"Targeting TNF-alpha receptors for neurotherapeutics.","volume":"31","author":"W Chadwick","year":"2008","journal-title":"Trends Neurosci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cytogfr.2008.04.010","article-title":"Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: mouse models.","volume":"19","author":"AA Kruglov","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.atherosclerosis.2006.08.030","article-title":"Diabetic atherosclerosis mouse models.","volume":"191","author":"KK Wu","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/01.RES.0000266449.37396.1f","article-title":"Recipes for creating animal models of diabetic cardiovascular disease.","volume":"100","author":"W Hsueh","year":"2007","journal-title":"Circ Res"},{"key":"ref35","article-title":"Tumor Necrosis Factor-\u03b1 Does Not Mediate Diabetes-Induced Vascular Inflammation in Mice.","author":"J Nilsson-\u00d6hman","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00702-005-0409-y","article-title":"Molecular mechanisms involved in T cell migration across the blood-brain barrier.","volume":"113","author":"B Engelhardt","year":"2006","journal-title":"J Neural Transm"},{"key":"ref37","first-page":"124","article-title":"Cheung N, Mitchell P, Wong TY Diabetic retinopathy.","volume":"376","journal-title":"The Lancet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e8158","DOI":"10.1371\/journal.pone.0008158","article-title":"Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.","volume":"4","author":"T Yoshimura","year":"2009","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/IAE.0b013e31816576d5","article-title":"Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales&apos; disease.","volume":"28","author":"P Murugeswari","year":"2008","journal-title":"Retina"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.eye.6702584","article-title":"Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy.","volume":"22","author":"JI Patel","year":"2008","journal-title":"Eye (Lond)"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1167\/iovs.06-0647","article-title":"Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration.","volume":"47","author":"TE de Gooyer","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2337\/diabetes.51.4.1172","article-title":"Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients.","volume":"51","author":"S Mohr","year":"2002","journal-title":"Diabetes"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/IAE.0b013e31815ec32d","article-title":"Inflammatory markers in nondiabetic and diabetic rat retinas exposed to ischemia followed by reperfusion.","volume":"28","author":"C Gustavsson","year":"2008","journal-title":"Retina"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00417-009-1289-x","article-title":"Johnsen-Soriano S, Sancho-Tello M, Arnal E, Navea A, Cervera E, et al. IL-2 and IFN-gamma in the retina of diabetic rats.","volume":"248","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1172\/JCI10373","article-title":"NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?","volume":"107","author":"T Collins","year":"2001","journal-title":"J Clin Invest"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1167\/iovs.04-1409","article-title":"The RAGE axis in early diabetic retinopathy.","volume":"46","author":"GR Barile","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/CS20080196","article-title":"Role of TNF-alpha in vascular dysfunction.","volume":"116","author":"H Zhang","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2796.2007.01852.x","article-title":"Obesity-induced inflammation: a metabolic dialogue in the language of inflammation.","volume":"262","author":"AW Ferrante Jr","year":"2007","journal-title":"J Intern Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e10091","DOI":"10.1371\/journal.pone.0010091","article-title":"Inflammation Determines the Pro -Adhesive Properties of High Extracellular D -Glucose in Human Endothelial Cells <italic>In Vitro<\/italic> and Rat Microvessels <italic>In Vitro<\/italic>.","volume":"5","author":"Vn Azcutia","journal-title":"PLoS ONE"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/intimm\/8.1.23","article-title":"Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice.","volume":"8","author":"HP Eugster","year":"1996","journal-title":"Int Immunol"},{"key":"ref51","first-page":"1418","article-title":"TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations.","volume":"15","author":"AM Joussen","year":"2009","journal-title":"Mol Vis"},{"key":"ref52","first-page":"532\u2013534, 536","article-title":"A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples.","volume":"15","author":"P Chomczynski","year":"1993","journal-title":"Biotechniques"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.metabol.2005.08.009","article-title":"Modifying a standard method allows simultaneous extraction of RNA and protein, enabling detection of enzymes in the rat retina with low expressions and protein levels.","volume":"55","author":"E Agardh","year":"2006","journal-title":"Metabolism"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.2337\/db06-1694","article-title":"Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.","volume":"56","author":"D Navaratna","year":"2007","journal-title":"Diabetes"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.metabol.2006.02.016","article-title":"Expression of antioxidant enzymes in rat retinal ischemia followed by reperfusion.","volume":"55","author":"CD Agardh","year":"2006","journal-title":"Metabolism"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1161\/01.CIR.90.4.1935","article-title":"Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits.","volume":"90","author":"S Ameli","year":"1994","journal-title":"Circulation"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.","volume":"18","author":"WT Friedewald","year":"1972","journal-title":"Clin Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0012699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T15:40:12Z","timestamp":1591890012000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0012699"}},"subtitle":[],"editor":[{"given":"Bernadette","family":"Breant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,9,13]]},"references-count":57,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2010,9,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0012699","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,13]]}}}